Cathay Biotech Inc. and 3P.COM Co. Limited have signed a strategic joint venture agreement that aims to advance the development of bio-based polyamide thermoplastic composites for critical applications, including hydrogen storage and transportation, urban air transport, and wind turbine blades. This partnership demonstrates their commitment to promoting sustainability in new energy, transportation, and related sectors while providing essential technical support to achieve net-zero emissions.
In a significant move towards sustainable innovation, Cathay Biotech, a leading developer and manufacturer of synthetic biomaterials, has formed a strategic alliance with 3P.COM, a company known for its extensive simulation expertise. This partnership intends to unlock the vast market potential of bio-based polyamide continuous fiber composites, poised to replace non-recyclable thermosets, aluminum, and steel in applications across new energy, modern transportation, and modern construction. Dr. Liu Xiucai, Chairman and President of Cathay Biotech, highlighted the objective of this Joint Venture (JV), stating, “The JV aims to be the final-step technological interface for these applications.”
Leveraging years of experience in composite development within the new energy and automotive sectors, Dr. Sung Kyu Ha, Chairman of 3P.COM, highlighted the practical advantages of Cathay’s bio-based polyamide continuous fiber composites in terms of performance and low-carbon footprint. Dr. Ha believes that the collaboration between Cathay and 3P.COM will deliver cutting-edge composite material technology and product solutions to global customers, offering substantial market scope and groundbreaking industrial significance.